Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anakinra for Rheumatoid Arthritis and Type 2 Diabetes (TRACK)
NCT02236481Phase 4Terminated
- Start
- Jul 2013
- Primary completion
- Dec 2017
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of anakinra in rheumatoid arthritis (RA) and type 2 diabetes mellitus (T2DM). Primary endpoint: Glycated Hemoglobin at 24 months. Started Jul 2013; status: terminated.
02
Drugs
anakinra
03
Conditions
rheumatoid arthritis (RA)type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02236481.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02236481.